PMID- 33429812
OWN - NLM
STAT- MEDLINE
DCOM- 20210122
LR  - 20240320
IS  - 1536-5964 (Electronic)
IS  - 0025-7974 (Print)
IS  - 0025-7974 (Linking)
VI  - 100
IP  - 1
DP  - 2021 Jan 8
TI  - Impact of lifestyle education for type 2 diabetes mellitus: Protocol for a 
      randomized controlled trial.
PG  - e24208
LID - 10.1097/MD.0000000000024208 [doi]
LID - e24208
AB  - OBJECTIVE: To explore the influence of the education of lifestyle in the type 2 
      diabetes mellitus (T2DM) patients with microalbuminuria as a part of the enhanced 
      multifactorial intervention. METHODS: This study will be conducted from May 2021 
      to August 2022 at Ningbo No.6 hospital. The experiment was granted through the 
      Research Ethics Committee of Ningbo No.6 hospital (539D035). The patients will be 
      included if they are between 18 and 65 years old and are diagnosed with T2DM with 
      microalbuminuria and the patients who have signed the written informed consent. 
      While the patients will be excluded if they have serious physical comorbidities 
      and patients who are unwilling to offer the informed consent to take part in this 
      experiment. We measure the clinical examination (fasting blood-glucose, 
      glycosylated hemoglobin and routine urine test) timely. Detail of daily dietary 
      intake and lifestyle factors are also recorded. RESULTS: Table 1 reflects the 
      comparison of the biochemical and clinical variables and the lifestyle factors. 
      CONCLUSION: Lifestyle education is effective in facilitating the control of T2DM 
      and reducing microalbuminuria. TRIAL REGISTRATION NUMBER: researchregistry6348.
CI  - Copyright (c) 2021 the Author(s). Published by Wolters Kluwer Health, Inc.
FAU - Zhu, Jingjing
AU  - Zhu J
AD  - Department of Endocrinology, Ningbo No.6 hospital, Zhejiang, China.
FAU - Chen, Min
AU  - Chen M
FAU - Pang, Yuzi
AU  - Pang Y
FAU - Li, Shumin
AU  - Li S
AUID- ORCID: 0000-0002-9822-5640
LA  - eng
GR  - 81779031/National Natural Science Foundation of China/
PT  - Clinical Trial Protocol
PT  - Journal Article
PL  - United States
TA  - Medicine (Baltimore)
JT  - Medicine
JID - 2985248R
SB  - IM
MH  - Albuminuria/complications
MH  - Diabetes Mellitus, Type 2/complications/*therapy
MH  - Humans
MH  - *Patient Education as Topic
MH  - *Risk-Taking
MH  - Randomized Controlled Trials as Topic
PMC - PMC7793339
COIS- The authors have no conflicts of interests to disclose.
EDAT- 2021/01/13 06:00
MHDA- 2021/01/23 06:00
PMCR- 2021/01/08
CRDT- 2021/01/12 01:15
PHST- 2020/12/10 00:00 [received]
PHST- 2020/12/15 00:00 [accepted]
PHST- 2021/01/12 01:15 [entrez]
PHST- 2021/01/13 06:00 [pubmed]
PHST- 2021/01/23 06:00 [medline]
PHST- 2021/01/08 00:00 [pmc-release]
AID - 00005792-202101080-00088 [pii]
AID - MD-D-20-12325 [pii]
AID - 10.1097/MD.0000000000024208 [doi]
PST - ppublish
SO  - Medicine (Baltimore). 2021 Jan 8;100(1):e24208. doi: 10.1097/MD.0000000000024208.